A Novel Replication Competent Flavivirus-based HIV Vaccine Platform ie RepliVax as a Priming Component for Improving Antibody Response

Project: Research project

Project Details

StatusFinished
Effective start/end date9/6/128/31/18

Funding

  • Gates (Bill and Melinda) Foundation: $671,044.00

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.